Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +4.17% | -1.37% | +2.04% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.04% | 20.26M | |
+14.76% | 109B | |
-1.24% | 29.49B | |
+15.90% | 23.1B | |
-12.51% | 18.52B | |
-6.80% | 17.38B | |
+15.53% | 16.24B | |
-4.17% | 12.29B | |
-0.74% | 10.63B | |
-4.52% | 9.52B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Unit, ENSCO Sign Drone Acquisition Deal